from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3389c/htdY

LFCtreatmentdescriptionclass of inhibitor

1.879

Amikacinug/mL Amikacintranslation

2.086

Cap5-10ug/mL Capreomycintranslation

1.391

Rox10-50 ug/mL Roxithromycintranslation

0.037

SM2-5 ug/mL Streptomycintranslation

2.381

Tet5-10 ug/mL Tetracyclinetranslation

-0.896

Rif0.2-5ug/mL Rifampicintranscription

0.034

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.312

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.776

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.182

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.742

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.063

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.243

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.657

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.227

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.369

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.579

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.331

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.972

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.148

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.350

KCN5-20 ug/mL Potassium cyaniderespiration

-0.429

NaN30.2-2 mM Sodium aziderespiration

0.066

Nigericin50 uM Nigericinrespiration

0.663

TRC10-150 ug/mL Triclosanrespiration

-0.714

TRZ10-25 ug/mL Thioridazinerespiration

-0.750

Valinomycin0.5-10 uM Valinomycinrespiration

0.061

ZnSO42 mM ZnSO4respiration

0.279

menadione6-10 ug/mL Menadionerespiration

-0.103

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.268

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.327

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.273

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.210

NRP_1Non-replicating persistence stage 1dosRassociated

0.139

Amp0.2mg/mL AmpicillincellWall

-0.012

Cephalexin20-100 ug/mL CephalexincellWall

0.599

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.490

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.424

EMB10-20 ug/mL EthambutolcellWall

-0.005

Eta12-40 ug/mL EthionamidecellWall

0.270

INH0.2-0.4 ug/mL IsoniazidcellWall

0.173

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.525

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.566

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.107

BZA0.12 mg/mL BenzamidearomaticAmides

0.117

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.398

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.836

H2O24 mM hydrogen peroxideDNAdamaging

0.289

Levo10 ug/mL LevofloxacinDNAdamaging

-0.508

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.188

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.640

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.156

UVUV-irradiationDNAdamaging

0.393

ARP41-4 ug/mL Antitubercular compound ARP4?

0.554

Antimycin12.5-50 ug/mL Antimycin A?

0.596

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.270

PA_110-50 ug/mL Antitubercular compound PA-1?

0.613

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.360

PA8240.2-2 ug/mL PA-824?

-1.037

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.593

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.039

Verapamil50 uM Verapamil?

0.315

mercaptoethanol2 mM 2-Mercaptoethanol?

0.312

methoxatin10-20 ug/mL Methoxatin?